Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer

NDAQ:APHA - Post by User

Aphria Inc.

<< Previous

Bullboard Posts

Next >>

Post by CaneIsAbelon Apr 28, 2021 8:57am

231 Views

Post# 33081161

Seeking Alpha today article. I will share aphria

tilray bit only. If you want to read entire article look it up. You may need subscription.
Cannabis stocks are in focus after Bank of America resumed coverage on several Canadian names in the sector including Canopy Growth, Tilray, and Cronos Group. But first on Cantor’s take on Humana - Kindred deal.
Bank of America has reinstated Tilray (NASDAQ:TLRY) with a buy rating and the price target of $23.00 per share indicates ~29.8% upside to the last close. Tilray is trading flat in before hours.
Anticipating Tilray – Aphria merger to close this quarter, the analyst Heather Balsky expects ‘multiple expansion’ thanks to the resultant gains in scale, efficiencies, and combined liquidity
The deal crossed a major hurdle a few days ago when Aphria (NASDAQ:APHA) shareholders approved the proposed merger between the two Canadian rivals.